We use own cookies and thirds to offer you better service More information Accept
Back to News

Mar. 2017

Profarma Program 2016 qualifies again Invent Farma as 'Very Good'


Invent Farma receives the qualification of “Very Good” in the Profarma Program for four consecutive years

By the end of February 2017, the resolution of the Profarma Program’s 2016 convocation which is annually called by the Spanish Ministry of Economy, Industry and Competitiveness has been made public. For four consecutive years, Invent Farma has been classified in Group A with the qualification of “Very Good”.

In the 2016 call, in which 56 companies have concurred, Invent Farma was classified again as one of the eight companies within the “Very Good” category. To achieve this classification ahead of larger companies is a great advantage for a company whose R&D is focused on the development of generics drugs.

Annually called with the main objective to favour the competitivity in the Pharmaceutical Industry in Spain, the Profarma Program groups the pharmaceutical companies in the categories of “Acceptable”, “Good”, “Very Good” or “Excellent”.

This result, achieved for four years in a row, is a new global recognition to the daily work of the Invent Farma Group's team and encourages us to continue working towards this direction.

See the Classification and qualification of the 2016 Profarma Program